5bmf
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | ''' | + | ==Crystal Structure of a Theophylline binding antibody Fab fragment== |
+ | <StructureSection load='5bmf' size='340' side='right' caption='[[5bmf]], [[Resolution|resolution]] 2.80Å' scene=''> | ||
+ | == Structural highlights == | ||
+ | <table><tr><td colspan='2'>[[5bmf]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5BMF OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5BMF FirstGlance]. <br> | ||
+ | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=4TJ:2-(5-{1-[1-(1,3-dimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)-4,15-dioxo-8,11-dioxa-5,14-diazaicosan-20-yl]-3,3-dimethyl-6-sulfo-1,3-dihydro-2H-indol-2-ylidene}penta-1,3-dien-1-yl)-1-ethyl-3,3-dimethyl-3H-indolium-5-sulfonate'>4TJ</scene></td></tr> | ||
+ | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5bmf FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5bmf OCA], [http://www.rcsb.org/pdb/explore.do?structureId=5bmf RCSB], [http://www.ebi.ac.uk/pdbsum/5bmf PDBsum]</span></td></tr> | ||
+ | </table> | ||
+ | <div style="background-color:#fffaf0;"> | ||
+ | == Publication Abstract from PubMed == | ||
+ | Knowledge of the three-dimensional structure of the antigen-binding region of antibodies enables numerous useful applications regarding the design and development of antibody-based drugs. We present a knowledge-based antibody structure prediction methodology that incorporates concepts that have arisen from an applied antibody engineering environment. The protocol exploits the rich and continuously growing supply of experimentally derived antibody structures available to predict CDR loop conformations and the packing of heavy and light chain quickly and without user intervention. The homology models are refined by a novel antibody-specific approach to adapt and rearrange sidechains based on their chemical environment. The method achieves very competitive all-atom root mean square deviation values in the order of 1.5 A on different evaluation datasets consisting of both known and previously unpublished antibody crystal structures. | ||
- | + | MoFvAb: modeling the Fv region of antibodies.,Bujotzek A, Fuchs A, Qu C, Benz J, Klostermann S, Antes I, Georges G MAbs. 2015 Jul 15:0. PMID:26176812<ref>PMID:26176812</ref> | |
- | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |
- | + | </div> | |
- | + | == References == | |
- | [[Category: | + | <references/> |
- | [[Category: | + | __TOC__ |
- | [[Category: | + | </StructureSection> |
+ | [[Category: Antes, I]] | ||
+ | [[Category: Benz, J]] | ||
+ | [[Category: Bujotzek, A]] | ||
[[Category: Changtao, Q]] | [[Category: Changtao, Q]] | ||
- | [[Category: Antes, I]] | ||
[[Category: Dengl, S]] | [[Category: Dengl, S]] | ||
+ | [[Category: Fuchs, A]] | ||
+ | [[Category: Georges, G]] | ||
[[Category: Hoffmann, E]] | [[Category: Hoffmann, E]] | ||
- | [[Category: | + | [[Category: Klostermann, S]] |
- | [[Category: | + | [[Category: Antibody]] |
- | [[Category: | + | [[Category: Hapten binding]] |
+ | [[Category: Immune system]] | ||
+ | [[Category: Theophylline]] |
Revision as of 14:42, 29 July 2015
Crystal Structure of a Theophylline binding antibody Fab fragment
|
Categories: Antes, I | Benz, J | Bujotzek, A | Changtao, Q | Dengl, S | Fuchs, A | Georges, G | Hoffmann, E | Klostermann, S | Antibody | Hapten binding | Immune system | Theophylline